Boxer Capital LLC Boosts Stock Position in Prometheus Biosciences, Inc.

Slightly above 67% of Prometheus Biosciences' investor base is looking to short. The analysis of current outlook of investing in Prometheus Biosciences suggests that many traders are alarmed regarding Prometheus Biosciences' prospects. Prometheus Biosciences' investing sentiment can be driven by a variety of factors including economic data, Prometheus Biosciences' earnings reports, geopolitical events, and overall market trends.
  
Boxer Capital LLC lifted its holdings in Prometheus Biosciences, Inc. by 10.7 percent during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,897,500 shares of the biopharmaceutical companys stock after purchasing an additional 183,500 shares during the period. Prometheus Biosciences accounts for approximately

Read at thelincolnianonline.com
news
  

Prometheus Biosciences Fundamental Analysis

We analyze Prometheus Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Prometheus Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Prometheus Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Prometheus Biosciences is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Prometheus Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Prometheus Biosciences stock to make a market-neutral strategy. Peer analysis of Prometheus Biosciences could also be used in its relative valuation, which is a method of valuing Prometheus Biosciences by comparing valuation metrics with similar companies.

Peers

Prometheus Biosciences Related Equities

PLRXPliant Therapeutics   4.49   
0%
79.0%
VKTXViking Therapeutics   3.06   
0%
54.0%
ACLXArcellx   1.88   
0%
33.0%
ETNB89bio   1.19   
0%
21.0%
IMVTImmunovant   0.85   
0%
15.0%
AKROAkero Therapeutics   0.40   
0%
7.0%
KRYSKrystal Biotech   0.00   
0%
0%
AMLXAmylyx Pharmaceuticals   0.94   
16.0%
0%
BPMCBlueprint Medicines   1.07   
18.0%
0%
APLSApellis Pharmaceuticals   1.25   
22.0%
0%
TERNTerns Pharmaceuticals   1.86   
32.0%
0%
ROIVRoivant Sciences   2.08   
36.0%
0%
STOKStoke Therapeutics   3.39   
59.0%
0%
DAWNDay One   4.36   
77.0%
0%
MDGLMadrigal Pharmaceuticals   5.66   
100.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in Prometheus Stock

If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios